Mark J. Murray

Direktor/Vorstandsmitglied bei Genevant Sciences Corp.

75 Jahre

Health Technology

Consumer Services

Aktive Positionen von Mark J. Murray

Unternehmen	Position	Beginn	Ende
Genevant Sciences Corp. Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen.	Direktor/Vorstandsmitglied	-	-

Unternehmen	Position	Beginn	Ende
ARBUTUS BIOPHARMA CORPORATION	Direktor/Vorstandsmitglied	14.10.2011	24.06.2019
	Vorstandsvorsitzender	30.05.2008	24.06.2019
	Präsident	30.05.2008	24.06.2019
Protiva Biotherapeutics, Inc. Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA.	Vorstandsvorsitzender	01.09.2000	02.12.2008
	Gründer	02.12.2008	02.12.2008
	Präsident	-	02.12.2008

Oregon Health & Science University

Doctorate Degree

International

Vereinigte Staaten	3
Kanada	3

Operativ

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ARBUTUS BIOPHARMA CORPORATION	Health Technology

Private Unternehmen	2
Protiva Biotherapeutics, Inc. Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA.	Health Technology
Genevant Sciences Corp. Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen.	Health Technology